ethyl acetate/obesity

CROSS-REFERENCE TO RELATED APPLICATION This application is a 371 of PCT/KR2009/007911, filed Dec. 29, 2009, the contents of which are incorporated herein by reference. TECHNICAL FIELD The present disclosure relates to fractions obtained from systematic fractionation of Polygonum Cuspidatum extracts,

BACKGROUND OF THE INVENTION Field of the Invention The invention in general pertains to compositions for adipogenesis inhibition. More specifically, the present invention discloses a composition comprising scirpusin A and scirpusin Band anti-adipogenesis/anti-obesity potential thereof. Description

BACKGROUND OF THE INVENTION Field of the Invention The invention in general pertains to compositions for adipogenesis inhibition. More specifically, the present invention disposes a composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof. Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Stage Application of International Application No. PCT/CN2013/075235 filed on May 7, 2013, and published in Chinese as WO 2013/174207 A1 on Nov. 28, 2013. This application claims priority to Chinese Application No.

FIELD OF THE INVENTION The present invention relates to a protein tyrosine phosphatase inhibitor, to method for preparing the same, and to use thereof in the manufacture of a pharmaceutical composition for the treatment and prevention of diabetes, obesity and cancers. BACKGROUND OF THE

CROSS-REFERENCE TO RELATED APPLICATION This U.S. application claims priority under 35 U.S.C. 371 to, and is a U.S. National Phase application of, the International Patent Application No. PCT/IN2015/000236, filed 10 Jun. 2015, which claims priority from Indian Patent Application No. 1614/DEL/2014